Related Experiment Videos

Langerhans cells, immunomodulation and skin lesions. A quantitative, morphological and clinical study

L Bergfelt1

  • 1Department of Dermatology, University of Göteborg, Sweden.

Insights

Immunosuppression reduces epidermal Langerhans cells (LCs), increasing skin tumor risk, particularly with long-term triple therapy. LCs are also altered in basal cell carcinoma (BCC).

Area of Science:

  • Immunodermatology
  • Oncology
  • Transplantation Immunology

Background:

  • Epidermal Langerhans cells (LCs) are crucial for skin immunity, presenting antigens to T lymphocytes and potentially defending against skin tumors.
  • Factors like aging, UV radiation, and immunosuppressive drugs can reduce LC numbers and function, potentially increasing skin cancer susceptibility.
  • Understanding LC roles in immunosurveillance is vital for managing skin health in immunocompromised individuals.

Purpose of the Study:

  • To investigate the importance of LCs in skin tumor immunosurveillance.
  • To evaluate LC number and morphology in unaffected skin of patients with cutaneous tumors and in immunosuppressed patients.
  • To examine LCs within basal cell carcinoma (BCC) and their association with inflammatory responses.

Main Methods:

  • Analyzed LC populations using ATPase and CD1a staining.
  • Assessed inflammatory response around BCC by quantifying HLA-DR+, CD3+, and ICAM-1+ cells.
  • Studied skin tumor prevalence in renal transplant recipients on various immunosuppressive regimens (azathioprine, prednisolone, cyclosporin) using light and confocal laser scanning microscopy (CLSM).

Main Results:

  • No significant difference in LC populations was found in patients treated with PUVA or those with skin tumors compared to controls; no age-related LC reduction was observed.
  • Immunosuppressed patients, especially those on triple drug therapy (cyclosporin+azathioprine+prednisolone), showed reduced LC numbers.
  • Long-term azathioprine and prednisolone treatment (10-25 years) correlated with a high prevalence of warts (40%) and skin tumors (29%), unlike shorter-term triple therapy.
  • LCs in the epidermis overlying BCC were decreased in number and altered in morphology compared to perilesional skin; dermal LCs were noted around BCC nests.

Conclusions:

  • The duration of immunosuppressive treatment is critical for the development of warts and skin tumors in transplant recipients.
  • While immunosuppression reduces LC numbers, this reduction does not necessarily correlate with treatment duration or the presence of skin lesions.
  • Alterations in epidermal LCs are associated with basal cell carcinoma, suggesting a role in tumor immunosurveillance.

Related Concept Videos